BioVoice eMagazine November 2022 Issue 2 Volume 3

0
306
Click to Read: BioVoice News November 2022 Issue 2 Volume 3
The Cover Story in the current edition turns its spotlight on the genetically modified mustard. Its recent approval by India’s biotech regulator has snowballed into a huge controversy. Given its high relevance for agriculture, we trace the journey of the supposedly first transgenic edible crop in India and its future.
Check out the exclusive interview with Ms. Chandra Ganjoo, Group Chief Executive Officer, Trivitron Healthcare that is full of fresh insights on policy initiatives, regulatory framework and outlook for the industry. Her views represent the feelings of the majority of domestic manufacturers of medical devices.
This edition is technology oriented. The respective expert insights on GM technology, digital health technology, and enzyme engineering bring new facts to the fore. Dr Ram Kaundinya, Director General, Federation of Seed Industry of India shares his thoughts on the recent approval to GM Mustard by GEAC and how can the stakeholders use it for farmer’s benefit. Naveen Kulkarni, CEO, Quantumzyme shares his views on how the digital interventions revolutionizing enzyme engineering. Dr Kanury V S Rao, Co-Founder & Chief Scientific Officer (CSO), PredOmix provides fresh perspective on the new-age technologies as a game changer in cancer testing.
The Startup Special features Chennai based LifeSigns which is using the digital technologies to improve healthcare affordability and accessibility for rural settings. In Trailblazers, read how drone technology in agriculture could help in bringing a paradigm shift. In Bio Special, we bring to you the top six agriculture technology companies with a promising future.
Click to Read: BioVoice News November 2022 Issue 2 Volume 3